Nebulized Aerosol Characteristics During Nasal High-Flow: Effect of Flow, Formulation and Impactor Temperature

Sasi Bhushan Yarragudi, Christina Koshy Vallipurayidathil, Andrew R. Martin, Stanislav Tatkov

Open source

DOI
10.3390/pharmaceutics18101234
Published
2026-09-29
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18101234,
  title = {Nebulized Aerosol Characteristics During Nasal High-Flow: Effect of Flow, Formulation and Impactor Temperature},
  author = {Sasi Bhushan Yarragudi and Christina Koshy Vallipurayidathil and Andrew R. Martin and Stanislav Tatkov},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18101234},
  url = {https://doi.org/10.3390/pharmaceutics18101234}
}

RIS

TY  - JOUR
TI  - Nebulized Aerosol Characteristics During Nasal High-Flow: Effect of Flow, Formulation and Impactor Temperature
AU  - Sasi Bhushan Yarragudi
AU  - Christina Koshy Vallipurayidathil
AU  - Andrew R. Martin
AU  - Stanislav Tatkov
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18101234
UR  - https://doi.org/10.3390/pharmaceutics18101234
ER  - 

APA

Yarragudi, S. B., Vallipurayidathil, C. K., Martin, A. R., & Tatkov, S. (2026). Nebulized Aerosol Characteristics During Nasal High-Flow: Effect of Flow, Formulation and Impactor Temperature. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18101234

Source records